
Framed in an inbound buyer brief as a pharmacovigilance/ICSR case management product of TrackWise Digital; no SKU under this name appears in Honeywell/Sparta's published product catalogue, and its existence at SKU level is unconfirmed.
The brief framed "TrackWise Digital Safety" as the pharmacovigilance / ICSR case management product of TrackWise Digital, described as an AI-powered cloud safety solution covering ICSR intake, MedDRA coding, E2B(R3) submissions to FDA FAERS / EudraVigilance / PMDA, aggregate reporting (PSUR/PBRER/DSUR/PADER), and signal detection.
No product named "TrackWise Digital Safety" appears in Honeywell/Sparta's current product taxonomy, which lists TrackWise Digital (QMS), TrackWise QMS (on-premise), TrackWise AI, TrackWise Manufacturing, TrackWise QMR, TrackWise PQR, and TrackWise Recall Management — none a dedicated PV/ICSR/E2B safety case management module.
The closest historical adjacency is a legacy module described in vendor collateral as "TrackWise Adverse Event Reporting", embedded within on-premise TrackWise QMS, supporting case intake, MedDRA-coded assessments of seriousness/causality/listedness, and electronic reporting. That module is not a cloud-native, Salesforce-platform, AI-powered PV system. Honeywell's public narrative treats pharmacovigilance as a planned future capability of the Connected Life Sciences vision rather than a shipping product.
Inherited, if the SKU exists, from the TrackWise Digital parent: multi-tenant SaaS on the Salesforce Lightning Platform-as-a-Service. Browser support is inherited from Salesforce Lightning (Chrome, Edge, Firefox, Safari). The product is mobile-enabled, with desktop and mobile access via Salesforce. SSO via SAML/Salesforce is inherited. A PV-specific attestation is not published. APIs run through the Salesforce REST library, supporting integration to ERP, MES, and data lakes. Standard Salesforce API rate limits apply by edition.
Data residency is inherited from Salesforce regions (US, EU, APAC, Japan). The vendor does not publish a PV-specific residency map. Data standards (E2B R2/R3, ICH-M2, HL7 FHIR/IDMP, MedDRA, WHODrug versions) are undisclosed for the PV SKU. A single-tenant option and a Salesforce Government Cloud option are both undisclosed.
No public list price. Per the vendor's pricing page, TrackWise Digital QMS pricing is "dependent on number of user licenses, processes, and implementation needs." It follows a standard subscription model with annual or multi-year licensing, quotation-based only.
A demo is available by request via "Request a Demo". A free trial is undisclosed. Deal sizes by segment, minimum commitments, setup fees, and validation-support fees are all undisclosed for a Safety SKU.
Undisclosed at the Safety SKU level: no typical timeline by organisation size is published.
Implementation, validation accelerators, and post-go-live support are sold as professional services. Sparta partner Techsol Life Sciences provides implementation, validation, and migration accelerators. Honeywell's own services arm offers Customer Success Manager engagement and the Sparta Training Academy. No vendor-published migration playbook exists for migrating from legacy safety databases. Migration risk factors common across the PV industry, independent of platform, include legal hold of legacy cases, MedDRA recoding across version updates, broken case linkages with partner reconciliation streams, and lifecycle data integrity during E2B(R3) re-export.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
User sentiment for the TrackWise QMS franchise (not PV-specific): users report TrackWise as "flexible and scalable," with strong CAPA, change-control, and audit traceability. One reviewer described the system as a "validation software of quality management" with audit-friendly behaviour and 21 CFR Part 11 compliance. Users also report a positive integration experience for change control: "All the change records are at our fingertips now. The search capability is our favorite feature; it's much more robust than our old QMS."
Critical commentary on TrackWise QMS (not PV-specific): "there are not a lot of options available for customization." The existence of a discrete TrackWise Digital Safety SKU is unconfirmed. No published evidence exists of an inspector-tested ICH E2B(R3) production track record across FDA AEMS, EudraVigilance, or PMDA.
Share your experience with TrackWise Digital Safety anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackJump to section